Skip to content
With the emergence of COVID-19 and the lack of timely response, the international community instantly realized that a foolproof plan for future pandemics is […]
Pharma recommends five essential priorities for future pandemic preparedness Read More »
Vulnerability to the impacts of climate change has been studied extensively in recent years but two new studies highlight specific impacts of changing weather
Human health seriously impacted by changing weather and air pollution Read More »
2023 is shaping up to be the year of RSV—in a good way. RSV (a.k.a. respiratory syncytial virus) has long been a challenge for
Pediatrics might finally have a long-awaited RSV shot Read More »
To assure the broad adoption of cutting-edge preventative measures that can shield Americans in the future, vaccine policy has to be changed, according to
Why vaccine policy must keep up with the science Read More »
Health and Human Services (HHS) is set to assess three drug payment models for Medicare and Medicaid in response to President Biden’s proposal to
HHS releases new drug payment models—here’s what you need to know Read More »
While research into long COVID-19 is offering clues to causes and potential targets for treatment, defeating this debilitating condition, which impacts millions, requires a
BIO’s online conference invites biotech to fight long COVID Read More »
Mexico yesterday announced a modified decree regarding U.S. imports of biotech corn for animal feed. However, the change does not appear to stop the ban on
UPDATED: Mexico issues modified decree on biotech corn – but it’s not enough Read More »
Last week, Reuters reported that Doug McKalip, the new U.S. Trade Representative’s (USTR) Chief Agricultural Trade Negotiator, told Mexico that it has “until Feb.
Mexico needs to ‘explain the science’ behind its corn ban Read More »
Already, 2023 is looking like a dynamic year for biotech on the state level as state legislatures nationwide get ready to tackle a few
4 things for biotech to watch in the 2023 state legislatures Read More »
On Thursday, the Centers for Medicare & Medicaid Services (CMS) released its proposed timeline for penalizing drug makers whose prices rise faster than inflation.
CMS releases timeline for inflation rebate on drug price increases Read More »
